{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"65.1","upperLimit":"96.9","value":"81.0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"27"}],"units":"Participants"}],"description":"Kaplan-Meier curves of OS will be plotted, and the proportion of responders to induction therapy will be tabulated.","dispersionType":"95% Confidence Interval","groups":[{"description":"Induction therapy + single myeloablative consolidation","id":"OG000","title":"Single HST (CEM)"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Up to 3 years","title":"OS in Patients 12-18 Months, Stage 4, MYCN Nonamplified Tumor/Unfavorable Histopathology/Diploid DNA Content/Indeterminant Histology/Ploidy and Patients > 547 Days, Stage 3, MYCN Nonamplified Tumor AND Unfavorable Histopathology/Indeterminant Histology","type":"SECONDARY","unitOfMeasure":"percent probability"}